Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

FBIO Stock Annual Income Statement. Download in Excel

Fortress Biotech Inc. logo

Fortress Biotech Inc.

Sector: Healthcare   

Industry: Biotechnology

1.72
 
USD
  
-0.04
  
(-2.27%)
Previous close: 1.76  Open: 1.77  Bid: 1.71  Ask: 1.75
52 week range    
1.24   
   4.43
Mkt Cap: 40 M  Avg Vol (90 Days): 575,767
Peers   
VCYT / 
EBS / 
ADXS / 
Last updated: Friday 8th November 2024

Stock Rankings

50
MarketXLS Rank
80
Value
15
Technical
55
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

FBIO Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends-299000.0-2 M-3 M-7 M-8 M8 M8 M
Amortization of intangibles-509000.0-2 M-1 M-1 M
Basic EPS from continuing operations-3.95-4.95-38.85-14.55-8.47
Basic EPS total-1.21-1.48-4.01-5.21-38.85-14.55-8.47
Basic weighted shares outstanding36 M39 M40 M42 M43 M4 M5 M5 M6 M8 M
BasicDiscontinuousOperations-0.06-0.26
CommissionExpenses10 M
Cost of sales-141000.0-24000.0-790000.04 M6 M11 M15 M42 M31 M27 M
Depreciation-23000.0-26000.0-400000.0-726000.0-1 M-2 M-2 M-3 M3 M2 M
Depreciation unreconciled545000.0
DepreciationAndAmortization-23000.0-26000.0-400000.0-726000.0-1 M-2 M-2 M-3 M3 M2 M
DevelopmentExpense75 M3 M16 M677000.04 M
Diluted EPS total-0.56-1.24-1.38-4.01-5.21-38.85-21.45-30.3-14.55-8.47
Diluted normalized net income/share-9.75-11.85-14.55-8.47
Diluted weighted shares outstanding36 M8 M130 M42 M43 M4 M5 M5 M6 M8 M
DilutedDiscontinuousOperations-11.7-18.45
Fees7 M104.0
GainOnSaleOfPPE18 M
GainOnSaleOfSecurity2 M18 M
GainsLossOnDisposalOfDiscontinuedOperations-2 M-13 M
GeneralAndAdministrativeExpense10 M-19 M28 M51 M53 M56 M-44 M-2 M114 M94 M
Gross operating profit141000.03 M32 M14 M-3 M-9 M31 M37 M45 M58 M
ImpairmentOfCapitalAssets-400000.03 M
Income before tax-20 M-54 M-71 M-98 M-131 M-102 M-103 M-164 M-214 M-154 M
Income restructuring and M&A-154000.0-200000.0
Income taxes-67 M-2 M-10 M-12 M136000.0473000.0449000.0521000.0
Interest income266000.0-3 M-76 M819000.01 M3 M-7 M25 M1 M3 M
InterestExpenseNonOperating-1 M-1 M-4 M-7687.0-10340.0-12 M10 M11 M10 M12 M
InterestExpenseOperating-9 M-10 M-11 M10 M12 M
MinorityInterests5 M16 M33 M58 M62 M56 M100 M127 M94 M
MiscOtherSpecialCharges942000.0-438000.0-1 M-9 M11 M23 M43 M63 M-9 M5 M
Net income from total operations-20 M-10 M-180 M-67 M-84 M-40 M-47 M-65 M-87 M-61 M
NetIncomeCommonStockholders-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-95 M-69 M
NetIncomeContinuousOperations-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-214 M-154 M
NetIncomeDiscontinuousOperations-2 M-11 M
NetIncomeFromOtherGainsLosses942000.0
NetNonOperatingInterestIncomeExpense266000.0-3 M-76 M819000.01 M3 M-7 M25 M1 M12 M
NonRecurringOperationExpense1000.0
Operating income-21 M-12 M-119 M-90 M-143 M-146 M-139 M-252 M-206 M-142 M
Operating income before depreciation (EBITDA)-22 M-55 M-72 M-93 M-126 M-114 M-88 M-146 M-192 M-131 M
OperatingExpense-21 M-51 M-82 M103 M141 M137 M125 M216 M249 M200 M
Other income net-942000.0438000.01 M9 M-11 M-42 M-43 M-63 M9 M1 M
Other special charges-17 M-16 M
OtherGainLossFromDispositionOfDiscontinuedOperations-810000.02 M
OtherGandA10 M-19 M28 M51 M53 M56 M-44 M-2 M114 M94 M
OtherImpairmentOfCapitalAssets-250000.0
OtherOperatingExpenses51 M82 M-107 M-6 M-3 M-3 M-3 M4 M3 M
OtherTaxes-400000.0
OtherunderPreferredStockDividend-299000.0-2 M-3 M-7 M-8 M8 M8 M
PreferredStockDividends-299000.0-2 M-3 M-7 M-8 M8 M8 M
RentAndLandingFees10 M-19 M28 M-1 M-2 M-2 M
Research & development expense10 M-18 M41 M52 M87 M81 M64 M129 M135 M106 M
ResearchExpense10 M-18 M41 M52 M87 M6 M61 M113 M134 M102 M
RestructringAndMnAIncome-154000.0-200000.0
Revenue per share-4 M-314000.0-692000.0-3141.0-2 M-4 M-7 M-4 M2 M3 M
SalariesAndWages-6 M-14 M-12 M-13 M-15 M-13 M-13 M-19 M
Selling Gen & administrative expense10 M-19 M28 M51 M53 M56 M61 M87 M114 M94 M
SellingAndMarketingExpense-3 M-6 M-10 M-12 M-17 M61 M87 M
SellingExpense61 M87 M
Special income/charges400000.0200000.017 M17 M-3 M
Total Income available for interest expense (EBIT)-22 M-55 M-75 M-98 M-131 M-122 M-93 M-153 M-203 M-142 M
Total common shares outstanding46 M49 M50 M51 M61 M5 M7 M7 M9 M23 M
Total net income-20 M-10 M-180 M-67 M-84 M-40 M-47 M-65 M-87 M-61 M
Total ordinary shares23 M23 M23 M23 M23 M23 M23 M23 M23 M23 M
Total revenues3 M33 M17 M4 M2 M1 M6 M73 M65 M
TotalExpenses-21 M-51 M-83 M107 M147 M147 M140 M257 M279 M227 M
TotalRevenue863000.016 M17 M4 M2 M1 M6 M73 M85 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University